Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Olaf Heidenreich.

Newcastle AuthorsTitleYearFull text
Dr Ricky Tirtakusuma
Dr Paul Milne
Dr Helen Blair
Yuzhe Shi
Dr Simon Bomken
et al.		Fusion transcripts are present in early progenitor cells in KMT2A-rearranged B-ALL2024
Dan Coleman
Dr Helen Blair
Sandeep Potluri
Professor Olaf Heidenreich
Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX12024
Professor Olaf Heidenreich
Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia2024
Dr Helen Blair
Dr Katarzyna Szoltysek
Rachel Cameron
Professor Olaf Heidenreich
The MLL-Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML2023
Dr Wei-yu Lin
Dr Sarah Fordham
Dr Nicola Sunter
Dr Claire Elstob
Dr Yaobo Xu
et al.		Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x)2022
Dr Deepali Pal
Dr Helen Blair
Sean Hockney
Dr Melanie Beckett
Mankaran Singh
et al.		hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia2022
Professor Olaf Heidenreich
PLCG1 is required for AML1-ETO leukemia stem cell self-renewal2022
Dr Laura Jardine
Dr Simone Webb
Justin Engelbert
Dr Owen Williams
Professor Olaf Heidenreich
et al.		Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia2022
Dr Wei-Yu Lin
Dr Sarah Fordham
Dr Nicola Sunter
Dr Claire Elstob
Dr Yaobo Xu
et al.		Genome-wide association study identifies susceptibility loci for acute myeloid leukemia2021